Note: This is a Forecasted Opportunity.
Birth defects affect about three percent of all births in the United States and are a leading cause of infant mortality, morbidity, and healthcare costs; the causes of two-thirds of birth defects remain unknown. In addition, stillbirths (pregnancy loss at 20 or more weeks of gestation) are an under-evaluated public health issue. Over 20,000 pregnancies in the U.S. end in a stillbirth each year.
This notice of funding opportunity aims to advance the quality and timeliness of birth defects and stillbirth surveillance and support research on birth defects and stillbirths in the U.S. The purpose is to (1) evaluate the impact of data modernization using electronic case reporting (eCR) on birth defects data quality and timeliness; (2) conduct high quality stillbirth surveillance; and (3) utilize timely surveillance to support a case-control study to assess risk factors for birth defects and stillbirths. This supports agency goals to identify emerging threats to mothers and babies and prevent the occurrence of birth defects and stillbirths. CDC will fund three components under this NOFO. Applicants may apply for one or more components as long as the eligibility criteria for each component are met.
Three components are included to support SUCCSSBD:
Component A: Modernization of Birth Defects Surveillance
Component B: Stillbirth Surveillance
Component C: Birth Defects and Stillbirth Research
Estimated Post Date:
Jan 29, 2027
Estimated Application Due Date:
Mar 31, 2027
Sponsor Institute/Organizations: Centers for Disease Control and Prevention
Sponsor Type: Government/Federal
Address: Centers for Disease Control and Prevention Office of Science Quality 1600 Clifton Road, NE Mail Stop D-72 Atlanta, Georgia 30333
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 31, 2027
Mar 31, 2027
Varies
Affiliation: Centers for Disease Control and Prevention
Address: Centers for Disease Control and Prevention Office of Science Quality 1600 Clifton Road, NE Mail Stop D-72 Atlanta, Georgia 30333
Website URL: https://www.zintellect.com/Opportunity/Details/CDC-NCCDPHP-DHDSP-2024-0148
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.